Baird Reiterates Buy Rating on IQVIA Holdings
Baird maintains its buy rating on IQVIA Holdings with a $249 price target, a 28.87% upside from the current price.
Key Points
- Baird reiterated its buy rating on IQVIA Holdings Inc. (NYSE:IQV) with a price target of $249 as of July 1, 2026.
- Baird's $249 price target implies 28.87% upside from IQVIA Holdings Inc.'s ($IQV) current $193.22 share price.
- On Wednesday, IQVIA shares were trading around $193.22, with a market cap of approximately $32.25 billion.
- Other analysts like Morgan Stanley and TD Cowen have varied ratings, with targets ranging from $200 to $221.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
On July 1, 2026, Baird reiterated its buy rating on IQVIA Holdings Inc. (NYSE:IQV), setting a price target of $249. This reflects continued confidence in the company by analyst Eric Coldwell. IQVIA shares were trading near $193.22 on Wednesday.
Baird vs. the S&P 500
Hypothetical, simulated performance of disclosed positions vs. the S&P 500. Not realized profit and not investment advice. Past performance does not indicate future results. Details.
IQVIA Holdings Inc. Stock Down 26.2%
IQVIA Holdings Inc. is a major player in the healthcare sector, specifically in diagnostics and research. The company has a market capitalization of about $32.25 billion. It trades on the NYSE under the ticker IQV. The stock has a P/E ratio of 24.0 and a forward P/E of 13.6, indicating expectations for growth. The beta of 1.215 suggests the stock is somewhat more volatile than the market. Over the past 52 weeks, the stock has ranged from $154.50 to $247.05, with a 50-day moving average of $174.50 and a 200-day moving average of $195.21.
$IQV price target
Past daily closes and this analyst's 12-month price target. Not investment advice.
Recent Earnings
IQVIA reported revenue of $16.63 billion, with a growth rate of 8.4%. The company achieved an EPS of $8.06, reflecting a net margin of 8.3% and a return on equity of 22.5%. The next earnings report is expected on July 21, 2026.
Insider Buying and Selling at IQVIA Holdings Inc.
Several insiders made purchases in May 2026. John Danhakl bought 185 shares at an average price of $178.64, while Colleen Goggins acquired 214 shares at the same price. Jim Fasano also made two purchases, one for 228 shares at $178.64 and another for 1,571 shares at $160.68. These transactions were not part of any pre-planned trading program.
Analysts Set New Price Targets
On July 1, 2026, Baird maintained its buy rating for IQVIA with a target price of $249. Morgan Stanley had earlier downgraded the stock to hold with a $200 target on June 17, 2026. Meanwhile, TD Cowen upgraded its rating to buy with a target of $213, showing a range of perspectives on the stock's potential.
About IQVIA Holdings
IQVIA Holdings Inc. provides a range of services to the life sciences industry, including clinical research, commercial insights, and healthcare intelligence. Based in Durham, North Carolina, the company operates through three main segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. Led by CEO Ari Bousbib, IQVIA employs around 93,000 people worldwide, delivering services that help improve healthcare outcomes.
Bottom Line
Baird's reiteration of a buy rating with a $249 target highlights continued confidence in IQVIA's growth prospects. Investors often track such analyst ratings to gauge market sentiment. It's important to note that ratings and targets are based on projections and can change over time.
Get IQVIA Holdings Inc. alerts
New 13F filings, insider trades, and analyst moves on $IQV, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.